Author: oncologs.com

The primary goal in cancer drug research is not merely to discover compounds that can destroy cancer cells, but to develop methods that specifically target and deliver these agents to cancer cells, sparing healthy ones. In many types of cancer, tumor cells have an overabundance

“We are optimistic that the incorporation of ADCs into the treatment of aggressive tumors and treatment refractory gynecologic cancers will improve quality of life and survival outcomes in our patients.” Credit: 2024 Greenman et al. “We are optimistic that the incorporation of ADCs into the

BALTIMORE, MD, July 12, 2024 — Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, new research suggests, which could contribute to higher rates of aggressive prostate cancer in African American men. The study, which was co-led by the University of Maryland

Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National Institutes of Health (NIH) genetically engineered normal white blood cells, known as lymphocytes, from each

EL PASO, Texas (July 11, 2024) – Researchers at The University of Texas at El Paso have made significant inroads in understanding how nanoplastics and per- and polyfluoroalkyl substances (PFAS) — commonly known as forever chemicals — disrupt biomolecular structure and function. The work shows

Mutations in the KRAS gene are the primary driver of pancreatic cancer. A new class of drugs known as KRAS inhibitors is showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment. Credit: Memorial Sloan Kettering Cancer Center Mutations in the KRAS gene are the primary

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in

“[…] it is crucial for the future application of ABC transporter inhibitors […] to develop a stratification protocol […] to identify those PDAC patients who are most likely to benefit from chemosensitization induced by these inhibitors.” Credit: 2024 Bergonzini et al. “[…] it is crucial

Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy have designed a novel type of cell to recognize and fight cancer. Credit: Elizabeth Cook Using genetic engineering techniques, investigators

HOUSTON – (July 10, 2024) – The Controlled Release Society (CRS), the premier international, multidisciplinary society dedicated to the science and technology of drug delivery, has elected Rice University bioengineer Omid Veiseh to its College of Fellows. Credit: Photo by Gustavo Raskosky/Rice University HOUSTON – (July